Eimear E Kenny | Icahn School of Medicine

Biography

Research Topics

Genetics, Genomics

Multi-Disciplinary Training Area

Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]

Education

BSc, Trinity College Dublin

MSc, University of Leeds

PhD, Rockefeller University

Post-doc, Stanford University

Publications

223

Publications

Selected Publications

Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database. Sanna Gudmundsson, Moriel Singer-Berk, Sarah L. Stenton, Julia K. Goodrich, Michael W. Wilson, Jonah Einson, Nicholas A. Watts, Xuefang Zhao, Robert Yolken, Mary T. Yohannes, Ramnik J. Xavier, Lauren Witzgall, James G. Wilson, Nicola Whiffin, Christopher Whelan, Maija Wessman, Ben Weisburd, Rinse K. Weersma, Hugh Watkins, James S. Ware, Qingbo Wang, Lily Wang, Arcturus Wang, Mark Walker, Gordon Wade, Christopher Vittal, Elisabet Vilella, Severine Vermeire, Marquis Vawter, Erkki Vartiainen, Teresa Tusie-Luna, Dan Turner, Tiinamaija Tuomi, Ming Tsuang, Charlotte Tolonen, Kathleen Tibbetts, Grace Tiao, Yik Ying Teo, Kent D. Taylor, Yekaterina Tarasova, Michael E. Talkowski, E. Shyong Tai, Jaana Suvisaari, Patrick F. Sullivan, Nathan O. Stitziel, Christine Stevens, Chelsea Lowther, Eimear E. Kenny, Erwin P. Bottinger, Maria Abreu. Nature Communications

Genetic determinants and genomic consequences of non-leukemogenic somatic point mutations. Joshua S. Weinstock, Sharjeel A. Chaudhry, Maria Ioannou, Maria Viskadourou, Paula Reventun, Yasminka A. Jakubek, L. Alexander Liggett, Cecelia Laurie, Jai G. Broome, Alyna Khan, Kent D. Taylor, Xiuqing Guo, Patricia A. Peyser, Eric Boerwinkle, Nathalie Chami, Eimear E. Kenny, Ruth J. Loos, Bruce M. Psaty, Russell P. Tracy, Jennifer A. Brody, Jeong H. Yun, Michael H. Cho, Ramachandran S. Vasan, Sharon L. Kardia, Jennifer A. Smith, Laura M. Raffield, Aurelian Bidulescu, Emily C. O’Brien, Mariza de Andrade, Jerome I. Rotter, Stephen S. Rich, Yii Der Ida Chen, C. Charles Gu, Chao A. Hsiung, Charles Kooperberg, Bernhard Haring, Rami Nassir, Rasika Mathias, Alex Reiner, Vijay G. Sankaran, Charles J. Lowenstein, Thomas W. Blackwell, Goncalo R. Abecasis, Albert V. Smith, Hyun M. Kang, Pradeep Natarajan, Siddhartha Jaiswal, Alexander Bick, Wendy S. Post, Paul Scheet, Paul Auer, Theodoros Karantanos, Alexis Battle, Marios Arvanitis. Nature Communications

Investigating the sources of variable impact of pathogenic variants in monogenic metabolic conditions. Angela Wei, Richard Border, Boyang Fu, Sinéad Cullina, Nadav Brandes, Seon Kyeong Jang, Sriram Sankararaman, Eimear E. Kenny, Miriam S. Udler, Vasilis Ntranos, Noah Zaitlen, Valerie A. Arboleda. Nature Communications

View All Publications

Video

Population Genomic Health: Bridging Genomics into Clinical Care

Office Locations

Annenberg Building Floor 18 Room 18

1468 Madison Ave

New York, NY 10029

212-241-3878

Annenberg Building Floor 18 Room 18

1468 Madison Ave

New York, NY 10029

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Kenny during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Board Service

Overtone
Galateo Bio

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

Galateo Bio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Kenny during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Board Service

Overtone
Galateo Bio

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

Galateo Bio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.